
Guinea-Bissau Halts US Vaccine Study Over Ethical Concerns
Guinea-Bissau has suspended a U.S.-funded hepatitis B vaccine study amid ethical concerns and questions about research practices in developing nations, sparking debate between U.S. and African health officials. The decision, influenced by recent political instability in Guinea-Bissau, highlights the complexities of conducting medical research across different regulatory and cultural landscapes, prompting a review involving international experts.
























